Simon Keane
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion.
Journal: NPJ precision oncology
Published: June 18, 2025
Increased MLH1, MGMT, and p16INK4a methylation levels in colon mucosa potentially useful as early risk marker of colon cancer.
Journal: Molecular & cellular oncology
Published: May 13, 2025
A pilocytic astrocytoma with novel ATG16L1::NTRK2 fusion responsive to larotrectinib: a case report with genomic and functional analysis.
Journal: The oncologist
Published: June 13, 2024
Novel TPR::ROS1 Fusion Gene Activates MAPK, PI3K and JAK/STAT Signaling in an Infant-type Pediatric Glioma.
Journal: Cancer genomics & proteomics
Published: June 27, 2022
Inflammation suppresses DLG2 expression decreasing inflammasome formation.
Journal: Journal of cancer research and clinical oncology
Published: January 26, 2022
Bioinformatics analysis of miRNAs in the neuroblastoma 11q-deleted region reveals a role of miR-548l in both 11q-deleted and MYCN amplified tumour cells.
Journal: Scientific reports
Published: November 17, 2021
DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma.
Journal: DNA repair
Published: July 06, 2021
Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib.
Journal: Cancer biology & therapy
Published: April 06, 2021
The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma.
Journal: Cancer cell international
Published: October 13, 2020
Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy.
Journal: PloS one
Published: February 04, 2020
Low DLG2 gene expression, a link between 11q-deleted and MYCN-amplified neuroblastoma, causes forced cell cycle progression, and predicts poor patient survival.
Journal: Cell communication and signaling : CCS
Published: January 09, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026